Angela Smith-Morgan to step down from her role as Co CEO of Leukaemia UK

After eight successful years with us, Angela Smith-Morgan will be stepping down from her role as Co CEO of Leukaemia UK on 3rd September.

Angela was responsible for driving through the merger with Leuka in November 2019, and is now leaving the charity in a strong position to build on the remarkable transformation she engineered.

She has been a valued Co CEO of the merged charity and a visionary sole CEO of the original charity. We thank her for her outstanding work on our behalf and wish her the very best in the future.

Latest

Research breakthrough targets cancer over healthy tissue, bringing possibility of a new treatment option for most deadly type of leukaemia

A new scientific paper published on 22nd June in Science Translational Medicine, announced a breakthrough by Leukaemia UK-funded scientist Dr William Grey that could lead to a vital new treatment option for patients with acute myeloid leukaemia.
One Cancer Voice writes to Sajid Javid ahead of 10-Year Cancer Plan

Today, with 50+ cancer charities, we are writing to The Secretary of State for Health & Social Care, Sajid Javid, setting out our expectation for next month’s 10-Year Cancer Plan.
In Loving Memory of Alice Young

To help research into Leukaemia
Sarah Weber

Head of Public Fundraising

Research breakthrough targets cancer over healthy tissue, bringing possibility of a new treatment option for most deadly type of leukaemia

A new scientific paper published on 22nd June in Science Translational Medicine, announced a breakthrough by Leukaemia UK-funded scientist Dr William Grey that could lead to a vital new treatment option for patients with acute myeloid leukaemia.
One Cancer Voice writes to Sajid Javid ahead of 10-Year Cancer Plan

Today, with 50+ cancer charities, we are writing to The Secretary of State for Health & Social Care, Sajid Javid, setting out our expectation for next month’s 10-Year Cancer Plan.
An open letter to people with a weakened immune system

Leukaemia UK joins the NHS and other charity leaders by signing an open letter, to encourage people with a weakened immune system to continue to book in or visit a walk-in centre for their Covid-19 vaccines.
Leukaemia UK reveals new strategy to go further than ever to stop leukaemia devastating lives

Leukaemia UK has revealed a new strategy to go further than ever to save and improve more lives, through research, awareness and advocacy.
Cancer charities unite in encouraging the Government to address crucial issues as part of their “War on Cancer”

In collaboration with our partners and as part of the One Cancer Voice group, Cancer 52 and Blood Cancer Alliance, we have called on the Government to take account of a wide range of recommendations as they finalise the 10-Year Cancer Plan to be announced later this year.
Leukaemia UK is looking for volunteers for their Patient Experience Advisory Panel

Leukaemia UK is committed to championing advancements in better treatments and care for all. We want to ensure the needs of patients are at the heart of everything we do, and that the voices of people affected by leukaemia and related conditions are being heard. That is why we are setting up a Patient Experience Advisory Panel.
Leukaemia UK launches search for five new talented Trustees

We are looking for a talented and diverse set of Trustees to join our Board, and help guide the charity as we embark on an ambitious new strategy to accelerate progress in leukaemia research to stop leukaemia devastating lives.
One Cancer Voice 10-Year Cancer Plan Consensus Statement

We have joined with 53 cancer charities to speak with One Cancer Voice and publish 10 tests that the Government's new 10-year Cancer Plan must meet if it is to be successful.
Inquiry highlights the impact of COVID-19 on blood cancer services

A new report has recently been published, following an inquiry by the All-Party Parliamentary Group (APPG) on Blood Cancer and the APPG on Stem Cell Transplantation and Advanced Cellular Therapies, on the impact of Covid-19 on blood cancer services in the UK.
New analysis reveals the stark disparities in cancer rates between ethnic groups

The Cancer Research UK study demonstrates the importance of understanding the differences and inequalities in cancer and to highlight where improvements in survival, treatment and care can be made.